- University Of Pittsburgh, BS, 2021
Education & Training
Sun R, Zhao H, Gao DS, Ni A, Li H, Chen L, Lu X, Chen K, Lu B. Amphiregulin couples IL1RL1+ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Sci Adv. 2023 Aug 25;9(34):eadd7399. doi: 10.1126/sciadv.add7399. Epub 2023 Aug 23. PMID: 37611111; PMCID: PMC10446484.
Sun R, Gao DS, Shoush J, Lu B. The IL-1 family in tumorigenesis and antitumor immunity. Semin Cancer Biol. 2022 Nov;86(Pt 2):280-295. doi: 10.1016/j.semcancer.2022.05.002. Epub 2022 May 14. PMID: 35580824.
Wu S, Huang H, Sun R, Gao DS, Ye F, Huang J, Li E, Ni A, Lu KG, Chen K, Jiang J, Morel PA, Zhong Z, Lu B. Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer Res Commun. 2023 Aug 4;3(8):1460-1472. doi: 10.1158/2767-9764.CRC-23-0012. PMID: 37546701; PMCID: PMC10402650.
Wu S, Sun R, Tan B, Chen B, Zhou W, Gao DS, Zhong J, Huang H, Jiang J, Lu B. The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy. Front Cell Dev Biol. 2021 Nov 15;9:779865. doi: 10.3389/fcell.2021.779865. PMID: 34869384; PMCID: PMC8634682.